Sinphar Pharmaceutical (Taiwan) Widgets and Gadgets
1734 Stock | TWD 30.85 0.25 0.82% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- 1734 Sinphar Pharmaceutical Co
- 1734 30.85 0.25
- Low 30.6
- High 30.95
- Volume 188.6 K
- Alpha -0.35
- Beta 0.55
- Return On Equity 0.0444
- Return On Asset 0.0207
- Profit Margin 0.07 %
- Operating Margin 0.07 %
- Current Valuation 6.26 B
- Shares Outstanding 167.72 M
- Shares Owned By Insiders 20.27 %
- Shares Owned By Institutions 1.49 %
- Price To Earning 536.84 X
- Price To Book 1.88 X
- Price To Sales 2.15 X
- Revenue 2.43 B
- Gross Profit 888.71 M
- EBITDA 109.64 M
- Net Income (38.13 M)
- Cash And Equivalents 937.43 M
- Cash Per Share 5.59 X
- Total Debt 1.49 B
- Debt To Equity 51.50 %
- Current Ratio 2.25 X
- Book Value Per Share 17.41 X
- Cash Flow From Operations 135.54 M
- Earnings Per Share 1.18 X
- Number Of Employees 26
- Beta 0.79
- Market Capitalization 5.4 B
- Total Asset 6.22 B
- Retained Earnings 237 M
- Working Capital 1.28 B
- Current Asset 2.28 B
- Current Liabilities 999 M
- Z Score 1.8
- Annual Yield 0.01 %
- Five Year Return 1.48 %
- Net Asset 6.22 B
- Last Dividend Paid 0.2
- Accumulation Distribution 2132.44
- Daily Balance Of Power 0.7143
- Rate Of Daily Change 1.01
- Day Median Price 30.78
- Day Typical Price 30.8
- Price Action Indicator 0.2
- Period Momentum Indicator 0.25
- Relative Strength Index 36.33
Market Snapshot Widget Example
DAX Index Germany | 19,626 1.03 | |
Taiwan Weighted Taiwan | 22,262 0.16 | |
PSI 20 Stock Portugal | 6,418 0.2 | |
CROBEX Croatia | 3,162 0.09 | |
Budapest SE Hungary | 77,936 0.56 | |
IDX 30 Jakarta Indonesia | 438.73 2.01 | |
ISEQ 20 Price Ireland | 1,611 1.06 | |
NYSE Comp USA | 20,272 0.31 | |
Tel Aviv 35 Israel | 2,260 0.72 | |
Coreshares Index Tracker South Afric | 1,080 2.35 | |
IPC MEXICO Mexico | 49,710 0.21 | |
KL Technology Malaysia | 58.48 0.43 | |
IBEX 35 Index Spain | 11,641 0.26 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,539 0.30 | |
SPASX Dividend Opportunities Australia | 1,697 0.03 | |
HNX 30 Vietnam | 479.79 0.88 | |
Bucharest BET-NG Romania | 1,193 1.32 | |
AMS Small Cap Netherlands | 1,227 1.00 | |
Oslo Exchange Mutual Norway | 1,410 0.22 | |
BEL Small Belgium | 8,012 0.4 | |
Basic Materials Brazil | 5,874 1.78 | |
Swiss Leader Price Switzerland | 1,938 0.35 | |
Fondo Mutuo ETF Chile | 1,367 0.39 | |
Athens General Comp Greece | 1,393 0.74 | |
Stock Exchange Of Thailand | 1,428 0.03 | |
PX Prague Stock Czech Repub | 1,688 0.07 | |
THE PHILIPPINE STOCK Philippines | 6,614 0.37 | |
WIG 30 Poland | 2,809 0.30 | |
BIST Electricity Turkey | 490.89 0.35 |
Investing Ideas
In addition to having Sinphar Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Sinphar Pharmaceutical
Compare Sinphar Pharmaceutical To Peers
Additional Tools for Sinphar Stock Analysis
When running Sinphar Pharmaceutical's price analysis, check to measure Sinphar Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinphar Pharmaceutical is operating at the current time. Most of Sinphar Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sinphar Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinphar Pharmaceutical's price. Additionally, you may evaluate how the addition of Sinphar Pharmaceutical to your portfolios can decrease your overall portfolio volatility.